anti HBs

Related by string. * ANTI . antis . Antis . www.anti . Anti : Anti Terrorism Squad ATS . Anti Terrorist Squad ATS . Anti Money Laundering . anti Sikh riots . anti dumping . Anti Doping Agency . World Anti Doping . Kenya Anti Corruption . anti . Malaysian Anti Corruption / HBS . HBD . Hb . HBED . hb : Solar Impulse HB SIA . By hb Jun . HB SIA prototype . By hb Jul . HB LEDs . hemoglobin Hb . Nabi HB . By hb Apr . HBS MBA * *

Related by context. All words. (Click for frequent words.) 72 antibody titer 70 HBsAg 69 eosinophil count 68 tryptase 68 serum cortisol 68 serum concentrations 68 HCV replicon 68 seropositivity 68 serum IgE 67 μg ml 67 HBV vaccine 67 serum antibody 67 HBeAg 67 NNRTI resistance 67 hemagglutination inhibition 67 immunoglobulin G 67 HER2 expression 66 BCG vaccinated 66 humoral responses 66 plasma pharmacokinetics 66 biochemical relapse 66 undetectable HBV DNA 66 hemagglutination inhibition HAI 66 seronegative 66 BALB c mice 66 antibody titers 66 neutrophil counts 65 elevated LDH 65 μmol L 65 Plasma concentrations 65 seroprotection 65 relapsed MM 65 chlamydial 65 triglyceride concentrations 65 HIV uninfected 65 daily subcutaneous injections 65 bFGF 65 mg kg dose 65 hepatitis B immunoglobulin 65 pituitary hormone 65 IU ml 65 hsCRP levels 65 neutrophil count 65 Immune responses 65 ertapenem 65 Kinoid 65 #mg dose [002] 65 papillary renal cell carcinoma 65 CIN2 + 65 hydroxyvitamin D levels 65 genotypic resistance 64 aspartate aminotransferase 64 lymphocyte counts 64 reactogenicity 64 serum TSH 64 intact parathyroid hormone 64 nmol 64 isoprostane 64 64 serum albumin 64 human chorionic gonadotropin hCG 64 evaluable subjects 64 RhD positive 64 isoproterenol 64 thyroid stimulating hormone 64 inecalcitol 64 MAGE A3 ASCI 64 vitamin B# folic acid 64 hydroxy vitamin D 64 serologic testing 64 sitosterol 64 HIV RNA 64 K ras mutations 64 inhibin B 64 seroprotective 64 serum aminotransferase levels 64 mIU ml 64 NAbs 64 lymphocyte count 64 serum calcium levels 64 IgG antibody 64 immunized mice 64 AST ALT 64 ß carotene 64 glucuronide 64 serum homocysteine 64 PSA nadir 64 HpSA 64 specific antigen PSA 64 #beta 64 PBMCs 64 trivalent influenza vaccine 64 IgM antibodies 64 mIU mL 64 aspartate aminotransferase AST 64 immunoreactivity 63 tipranavir r 63 μg mL 63 dose cohort 63 complete cytogenetic response 63 rFSH 63 uM 63 plasma folate 63 #ng/ml 63 tumorigenicity 63 umol L 63 bronchoalveolar lavage 63 quadrivalent vaccine 63 anti HBc 63 oestradiol 63 SGPT 63 serum LDL cholesterol 63 postexposure 63 pT3 63 isoenzyme 63 bioavailable testosterone 63 folate concentrations 63 fosamprenavir 63 bovine thrombin 63 serum lipid levels 63 inhibin 63 HER2 amplification 63 heparanase 63 glutamyl 63 Inhibin B 63 mU liter 63 PASI scores 63 indinavir 63 antiandrogen 63 lactate dehydrogenase 63 advanced adenoma 63 β carotene 63 cobalamin 63 pmol L 63 GHRH 63 serum testosterone 63 lactate dehydrogenase LDH 63 lupus anticoagulant 63 elastase 63 HPV-#/# 63 peritoneal fluid 63 nonnucleoside reverse transcriptase inhibitors 63 CC genotype 63 COPEGUS therapy 63 virologic responses 63 hypogonadal 63 busulfan 63 hMG 63 hepatoma 63 Bezielle 63 serum creatinine levels 63 p# antigen 63 serum phosphate levels 63 antiviral efficacy 63 ß amyloid 63 clodronate 63 hemoglobin Hb 63 glycated 63 caspofungin 63 NNRTI resistant virus 63 sUA 63 Viral load 63 IFN gamma 63 CD# upregulation 63 ovarian carcinoma 62 azelaic acid 62 follicular fluid 62 replicon 62 mutated K ras 62 alanine aminotransferase 62 serotonin synthesis 62 paricalcitol 62 hepatocellular carcinomas 62 homocysteine concentrations 62 histological subtype 62 titers 62 serum IGF 62 capsular polysaccharide 62 administered intramuscularly 62 invasive carcinomas 62 Immunohistochemical staining 62 C. pneumoniae 62 anagrelide 62 IgG antibodies 62 parasitemia 62 supernatants 62 iPTH 62 nelfinavir 62 Belerofon 62 triiodothyronine 62 aminotransferase 62 aminotransferases 62 ERalpha 62 alanine aminotransferase ALT 62 LAB CGRP 62 nanomolar 62 pentoxifylline 62 plasma leptin 62 maternal serum 62 HCV antibody 62 euthyroid 62 transferrin saturation 62 serum calcium 62 ritonavir boosted protease inhibitor 62 PROSTVAC VF 62 antibody titres 62 methylmalonic acid 62 transaminase elevations 62 ritonavir boosted lopinavir 62 serologic 62 serum phosphate 62 N telopeptide 62 vWF 62 prostate carcinoma 62 Immunohistochemical analysis 62 GSTT1 62 HPV subtypes 62 tinzaparin 62 colorectal tumor 62 thyroglobulin 62 detectable HCV RNA 62 vaccinees 62 pharmacokinetic PK profile 62 interferon IFN 62 transdermal estradiol 62 bezafibrate 62 demonstrated antitumor activity 62 paraprotein 62 HGPIN 62 antigen PSA levels 62 elevated ALT 62 pharmacodynamic PD 62 genital secretions 62 infused intravenously 62 IgG1 62 Multimeric 62 cTnI 62 viraemia 62 recurrent UTI 62 lymphocytosis 62 Immunoglobulin 62 TIMP 1 62 griseofulvin 62 pharmacokinetic parameters 62 ELISpot 62 HIV HCV coinfected 62 immunostaining 62 microg 62 gonadotropins 62 intranasally administered 62 thyrotropin 62 dehydroepiandrosterone sulfate 62 saline placebo 62 urocortin 2 62 #mg/day [002] 62 GSTP1 62 colorectal adenoma 62 TNF α 62 tHcy 62 HIV coinfected 62 mitoxantrone plus 62 IFN γ 62 posttreatment 62 μg L 61 interleukin IL -# 61 alpha1 61 TT genotype 61 HAAH 61 thyroid carcinoma 61 5 Fluorouracil 61 VCAM 1 61 HBeAg positive patients 61 apolipoprotein B 61 Rh factor 61 alkaline phosphatase ALP 61 subcutaneously injected 61 Pharmacokinetics PK 61 leukocyte count 61 fructosamine 61 external genital lesions 61 viral titers 61 serum retinol 61 IgG2 61 E. faecalis 61 % CI #.#-#.# [003] 61 serum urate levels 61 Mg Uk 61 pamidronate 61 TNFalpha 61 nutlin 3a 61 lymphocyte proliferation 61 liver histology 61 Parathyroid Hormone 61 Aptivus ® 61 pharmacokinetic characteristics 61 cervical intraepithelial neoplasia 61 KRAS mutations 61 radiotherapy RT 61 orally administered inhibitor 61 CANCIDAS 61 pg ml 61 virologic failure 61 weekly subcutaneous injections 61 achieved CCyR 61 mcg dose 61 protein excretion 61 #OHD 61 pathophysiological effects 61 antibody responses 61 #mg ATC 61 fluconazole resistant 61 induces antibodies 61 gastric adenocarcinoma 61 serum prostate 61 HepG2 cells 61 p# activation 61 renal cell carcinomas 61 TNF blocker therapy 61 nmol L. 61 IgA antibodies 61 favorable pharmacokinetic profile 61 NRTI resistance 61 radioiodine therapy 61 ASCUS 61 Leydig cells 61 HBeAg seroconversion 61 abacavir lamivudine 61 eotaxin 61 KRAS mutations occur 61 flavopiridol 61 ChronVac C 61 beta carotene supplementation 61 redox active 61 completely resected 61 tetanus toxoid 61 UGT#A# * 61 endometrial biopsies 61 parous women 61 CTAP# Capsules 61 squamous intraepithelial lesions 61 mucosal inflammation 61 locoregional recurrence 61 PlGF 61 histologic subtype 61 RiVax 61 IgM 61 dosing cohort 61 trastuzumab Herceptin ® 61 seroconverted 61 CR nPR 61 BENICAR HCT 61 coadministration 61 intestinal mucosal 61 transaminase levels 61 undetectable viral 61 fumagillin nanoparticles 61 HBV infections 61 lysosomal enzyme iduronate 61 hemodynamically significant 61 antithyroid 61 thyroid peroxidase 61 advanced adenomas 61 viremia 61 vaccine serotypes 61 VEGFR1 61 posttransplant 61 receptor blocker 61 progesterone receptor 61 Monocyte 61 interleukin IL -6 61 syngeneic 61 pyrazinamide 61 GRNVAC1 61 ara C 61 B7 H3 61 immunological responses 61 mcg mL 61 statin monotherapy 61 TRAIL R1 61 glycosylated hemoglobin HbA1c 61 basal cell nevus syndrome 61 fetal malformations 61 S. aureus isolates 61 Serum concentrations 61 Telintra 61 Jurkat cells 61 extracapsular extension 61 Vidaza azacitidine 61 HBV DNA levels 61 serum ferritin 61 thalidomide Thalomid 61 Subgroup analysis 61 immunodeficient 61 epoetin alpha 61 olmesartan 61 lanthanum carbonate 61 ALT flares 61 baseline LDH 61 antiangiogenic therapy 61 CCyR 61 p# Shc 61 ascorbate 61 granulocyte 61 peripheral blood mononuclear 60 mg/m2 dose 60 IFN α 60 CD4 + cells 60 BARACLUDE ® 60 myeloperoxidase 60 steroid dexamethasone 60 Wistar rats 60 unconjugated 60 macrophage infiltration 60 #OHD levels 60 RhD negative 60 heterozygotes 60 mmol liter 60 serum phosphorus levels 60 ELISPOT 60 PON1 enzyme 60 HCV genotype 60 culture supernatants 60 TRAIL R2 60 antiandrogens 60 seroconversion 60 bronchoalveolar 60 poor metabolizers 60 immune modulating 60 Apolipoprotein B 60 thyroid hormone replacement 60 pCR 60 μg liter 60 FDG uptake 60 Endometrial 60 airway responsiveness 60 nmol L 60 antithymocyte globulin 60 pDCs 60 systemic hypotension 60 cefazolin 60 recurrent metastatic 60 undergone splenectomy 60 potent inducer 60 glycosylated hemoglobin levels 60 urinary excretion 60 pharmacologically active isomer 60 carotid bruit 60 AZT zidovudine Retrovir 60 grade cervical intraepithelial 60 bronchoalveolar lavage fluid 60 Xanafide 60 neutropenic sepsis 60 flutamide 60 intradermal injection 60 8 OHdG 60 intradermal injections 60 cells μL 60 cervical lesions 60 hemoglobin A1c HbA1c 60 rtPA 60 histologically confirmed 60 palivizumab 60 neurologic progression 60 thromboxane A2 60 myometrium 60 enteroviral 60 HBV DNA 60 tTG 60 injected subcutaneously 60 immunopathology 60 macrolide antibiotic 60 nicardipine 60 lenalidomide Revlimid R 60 creatinine levels 60 cortisol concentrations 60 anti JCV antibodies 60 APTIVUS r 60 nephrotoxicity 60 fluvastatin 60 FluCAM arm 60 T SPOT.TB 60 BEXXAR Therapeutic Regimen 60 urine albumin 60 inducible nitric oxide synthase 60 pyrimidines 60 EGFR TKI 60 lymphovascular invasion 60 log# copies mL 60 pegylated IFN 60 MGd 60 REYATAZ r arm 60 phosphorylated tau 60 BRAF mutations 60 proteinase 60 Enterobacter cloacae 60 TIMP 60 erythropoietic 60 XOMA 3AB 60 serum PSA 60 tPSA 60 elevated transaminases 60 ddI 60 Calcium intake 60 CD4 lymphocyte count 60 #ug [002] 60 ERK activation 60 transaminases 60 endometrial hyperplasia 60 MBq 60 neutralizing antibody 60 glycated hemoglobin levels 60 cefotaxime 60 CD4 + T lymphocytes 60 tuberculin skin testing 60 hemoglobin concentration 60 5alpha reductase 60 activin 60 GnRH antagonist 60 dexamethasone Decadron 60 leucopenia 60 norethindrone 60 idiopathic membranous nephropathy 60 IV bisphosphonates 60 IFN beta 60 CLA supplementation 60 thymidine kinase 60 FOSRENOL ® 60 ritonavir boosted 60 pharmacokinetic interactions 60 factor HGF 60 ug mL 60 galiximab 60 vitamin D calcium 60 PENNVAX B 60 pg mL 60 prednisone prednisolone 60 serum antibodies 60 PEG IFN 60 serum PTH 60 menadione 60 Cystatin C 60 neutralizing antibodies 60 specific IgE 60 hypercalciuria 60 maximally tolerated dose 60 fasting plasma 60 cynomolgus monkeys 60 humanised monoclonal antibody 60 nephrotoxic 60 plasma renin activity 60 dose dependently 60 piperacillin tazobactam 60 fibrin deposition 60 IGFBP 60 monocyte chemoattractant protein 60 ALT elevation 60 aminotransferase levels 60 polymyxin B 60 natriuretic peptides 60 riociguat 60 adrenal suppression 60 cytokeratin 60 DRB1 * 60 paraoxonase 60 pretransplant 60 HbF 60 viremic 60 Poly ICLC 60 RBC folate 60 AGHD 60 gm dl 60 hypophosphatemia 60 thyroid stimulating hormone TSH 60 alpha fetoprotein AFP 60 ENMD # 60 gestational hypertension 60 ancrod 60 carcinoembryonic antigen 60 visceral metastases 60 hematological parameters 60 antiretroviral naïve 60 LPS induced 60 hematopoietic cancers 60 transthyretin 60 SCIg 60 effector function 60 bacteriuria 60 CYP #A# 60 trophoblast cells 60 imatinib therapy 60 serum phosphorous 60 bolus dose 60 mesalamine granules 60 molecular remissions 60 PENNVAX ™ B 60 SGOT 60 procollagen 60 p# biomarker 60 umbilical vein 60 variant alleles 60 immune globulins 60 ng ml 60 fasting plasma glucose FPG 60 Prostate specific antigen 60 serum IgG 60 elevated CRP 60 HBeAg negative 60 β blockers 60 null mice 60 HLA A2 60 median CD4 60 isotypes 60 ACTH 60 nucleotide analog 60 pegylated alpha interferon 59 epithelial barrier 59 gastric carcinoma 59 symptomatic intracranial hemorrhage 59 induced anemia 59 purified protein 59 azilsartan medoxomil 59 induced sputum 59 thyroxine T4 59 rhGH 59 obstructive coronary artery 59 nanomolar range 59 CRp 59 receiving immunosuppressive therapy 59 Engerix B 59 Alkaline Phosphatase 59 weekly intravenous infusions 59 LH FSH 59 intracranial hemorrhage ICH 59 mL/min/#.# m 2 59 folinic acid 59 highly immunogenic 59 PIGF 59 lopinavir 59 troponin T 59 D Dimer 59 acylated ghrelin 59 metaplasia 59 sFlt 1 59 hydroxychloroquine 59 preterm neonates 59 inflammatory biomarkers 59 bactericidal activity 59 antigenicity 59 seropositive 59 LDL oxidation 59 hormone receptor negative 59 serologically 59 cTnT 59 EDARBI 59 metastatic lymph nodes 59 IFN g 59 posaconazole 59 lavage fluid 59 forskolin 59 histologically proven 59 PegIFN RBV 59 glucocorticoid induced 59 airway hyper responsiveness 59 microvessel density 59 lymph node metastasis 59 CD#c 59 peroxidation 59 hyperoxia 59 progestagen 59 cisplatin resistant 59 hA# 59 follicle stimulating hormone FSH 59 59 mediated immunity 59 HER2 receptor 59 oral rivaroxaban 59 coinfection 59 EGFRIs 59 albumin protein 59 Clusterin 59 LRAT 59 neovascular 59 anemia hemoglobin 59 iron supplementation 59 KRAS mutation 59 polyp recurrence 59 glomerular filtration 59 alveolar epithelial cells 59 corticotropin releasing hormone 59 solithromycin 59 Creatinine 59 swab specimens 59 chronic HBV 59 GPx 59 creatinine ratio 59 administered subcutaneously 59 imipenem 59 topical gel containing 59 hemagglutination 59 receptor inhibitor 59 erythrocyte 59 G CSFs 59 HI titers 59 erythrocytes 59 ELISPOT assay 59 postoperative chemotherapy 59 grade squamous intraepithelial 59 allogeneic transplant 59 Serum creatinine 59 systemic toxicity 59 log# reduction 59 advanced neoplasia 59 Angiotensin converting enzyme 59 tumor necrosis 59 nitroprusside 59 selective modulator 59 hormone receptor status 59 pharmacodynamic effects 59 pharmacokinetics PK 59 plasma lipid 59 LEXIVA r 59 pretreatment serum 59 MenACWY 59 adjuvant cisplatin 59 postmenopausal estrogen 59 serum urate 59 CMV infection 59 4CMenB 59 corticosteroid therapy 59 assay detects 59 plasmid encoding 59 proinflammatory mediators 59 nmol liter 59 epithelial tumors 59 postexposure prophylaxis 59 tuberculin test 59 glutathione GSH 59 rhEPO 59 inotropic 59 #.#ng/ml 59 endothelial activation 59 IFNg 59 steroidogenic 59 moderate renal impairment 59 invasive lobular 59 Neutrophil 59 #β estradiol 59 micrometastasis 59 certolizumab 59 HBeAg negative patients 59 immunochemical 59 serum leptin 59 H. influenzae 59 peginterferon alfa 59 D dimer 59 serum potassium 59 kaempferol 59 PANVAC VF 59 urinary N telopeptide 59 gamma glutamyl 59 VZV 59 treatment naive genotype 59 mcg BID 59 vasoactive 59 low expressors 59 overt nephropathy 59 CD8 T cell 59 TURBT 59 Adverse effects 59 adalimumab Humira 59 trivalent inactivated influenza 59 HER2/neu 59 bladder carcinoma 59 oral antidiabetes 59 nM 59 HBeAg + 59 globulins 59 mmol l 59 alteplase 59 urine cytology 59 E selectin 59 hepatic enzyme 59 L lysine 59 haematopoietic 59 systemically administered 59 colorectal neoplasms 59 CD4 + CD# 59 microsomal 59 oncogenic HPV 59 Interferon beta 1b 59 urothelial carcinoma 59 ALT elevations 59 maternally derived 59 VivaGel TM 59 urinary oxalate 59 sarcomatoid 59 lymphomas leukemias 59 microgram kg 59 novel VDA molecule 59 KRAS status 59 serum estradiol 59 Vacc 4x 59 transgene expression 59 mmol kg 59 interferon γ 59 salmeterol fluticasone 59 LNG IUS 59 antitumor effect 59 HbA 1c levels 59 globulin 59 complete cytogenetic 59 underwent surgical resection 59 hepatic fibrosis 59 H pylori 59 Valortim ® 59 enteric bacteria 59 Lp PLA 2 59 rHuEPO 59 K#R [002] 59 administered intranasally 59 tylosin 59 STELARA ® 59 CLL SLL 59 interferon alfa 2b 59 ug ml 59 nitrosothiols 59 hepatic enzymes 59 Peginterferon 59 S. enterica 59 μg d 59 BRAF V#E mutation 59 Elitek 59 response CCyR 59 intravenous bisphosphonates 59 imiquimod cream 59 leukotriene B4 59 Elevated serum 59 hematologic abnormalities 59 immune globulin intravenous 59 #mmHg [001] 59 concomitant antibiotics 59 ergocalciferol 59 cardiac troponin T 59 progesterone receptor negative 59 selectively inhibited 59 Heterozygous 59 achieved ACR# 59 thrombin receptor 59 cytoprotective 59 SHBG levels 59 metastatic malignant 59 latent tuberculosis infection 59 leukocytosis 59 endometrial thickness 59 plasma triglycerides 59 telomerase inhibition 59 tipranavir ritonavir 59 mucosal tissue 59 cells multiply uncontrollably 59 deoxyglucose 59 pegylated liposomal doxorubicin 59 Non inferiority 59 biologic DMARD 59 oral prednisone 59 discontinued Viread 59 anthracycline containing 59 osteoblast 59 selenium supplementation 59 plasma uric acid 59 Hair follicle 59 serum vitamin D 59 oxcarbazepine 59 IOP lowering 59 baseline neutrophil counts 59 DFMO 59 μg dL 59 malignant ascites 59 pelvic ultrasound 59 Ribavirin causes 59 UGT#A# 59 nonvaccine 59 GH deficiency 59 cranial irradiation 59 folic acid vitamin B6 59 Dietary fat 59 blood glucose concentrations 59 virologic 58 systemic bioavailability 58 microsatellite instability 58 orofacial clefts 58 varicella chickenpox 58 antidiabetic medications 58 lumbar spine BMD 58 #beta estradiol 58 administered concomitantly 58 α tocopherol 58 comparator arm 58 PTHrP 58 MP4OX 58 intratumoral 58 PSMA ADC 58 pyrimethamine 58 Platelet counts 58 metastatic prostate 58 TNF antagonist 58 adipogenic 58 adriamycin 58 onset diabetes mellitus 58 intranasally 58 â ‰ ¥ 58 serum uric acid 58 aluminum hydroxide adjuvant 58 ZFN modified cells 58 PRTX 58 corticosteroid dose 58 im peramivir 58 dosing frequency 58 Pegylated Interferon 58 UPLYSO 58 Virulizin ® 58 thyrotropin levels 58 uninfected mice 58 antiretroviral naive 58 baseline CD4 58 histological examination 58 LHRH receptor positive 58 ribavirin therapy 58 PDGF B 58 bronchoalveolar lavage BAL 58 chlamydial infection 58 HER2 overexpression 58 IgG4 58 Interferon alpha 58 liver transaminases 58 histopathologic examination 58 Hgb 58 osteoprotegerin 58 micafungin 58 oral clodronate 58 doxorubicin docetaxel 58 vivo potency 58 intramuscularly 58 lymphopenia 58 ALT normalization 58 Pgp 58 SLNB 58 FUSILEV enhances 58 CD4 CD8 58 thrombocytopenic 58 metastatic lesions 58 Forodesine HCl 58 CYP#D# genotype 58 hypericin 58 Capesaris 58 nonpregnant 58 triacylglycerol 58 P. acnes 58 GnRH agonist 58 urinary calcium 58 hypermethylated 58 pyridostigmine 58 6mg 58 A. phagocytophilum 58 EXJADE 58 prostanoid 58 radiochemotherapy 58 piperonyl butoxide 58 Ad5 vector 58 mucinous 58 hepatitis B infection 58 cells uL 58 multivariable analysis 58 CIN3 + 58 severe neutropenia 58 chemoresistant 58 adrenocorticotropic hormone 58 mammaglobin 58 Doxil ® 58 IGFBP 3 58 plasma lipids 58 T1c 58 precursor lesions 58 expressors 58 DEB# 58 ethambutol 58 IgA deficiency 58 clomipramine 58 virologically 58 platelet reactivity 58 antithrombin III 58 osteoblastic 58 divalproex sodium 58 thyroid hormone levels 58 androgen suppression 58 univariate analysis 58 intima media thickness 58 acromegalic patients 58 VP# [004] 58 cephalosporin antibiotics

Back to home page